MicroRNA-29a-3p regulates abdominal aortic aneurysm development and progression via direct interaction with PTEN

Yuan Zhou1, Meigui Wang1, Jing Zhang2

  • 1Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

Insights

MicroRNA-29a-3p plays a key role in abdominal aortic aneurysm (AAA) development by targeting PTEN. Downregulating miR-29a-3p reduces AAA cell viability, offering potential therapeutic strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial in regulating physiological processes and disease pathogenesis.
  • Abdominal aortic aneurysm (AAA) is a life-threatening condition with complex molecular mechanisms.
  • Understanding miRNA involvement in AAA is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of miR-29a-3p in the development and progression of abdominal aortic aneurysm (AAA).
  • To elucidate the association between miR-29a-3p and phosphatase and tensin homolog (PTEN) in AAA pathogenesis.
  • To explore potential therapeutic targets for AAA based on miRNA-PTEN interactions.

Main Methods:

  • Quantitative real-time polymerase chain reaction (RT-qPCR) to assess gene expression.
  • Cell transfection to modulate gene expression, followed by cell viability assays (Cell Counting Kit-8).
  • Analysis of proliferation and apoptosis markers, luciferase assays, western blotting, and bioinformatics (TargetScan 4.2).

Main Results:

  • Increased miR-29a-3p expression was observed in AAA-mimic cells, correlating with higher cell viability and apoptosis.
  • Downregulation of miR-29a-3p significantly reduced the viability of AAA cells.
  • Bioinformatics and experimental data confirmed that PTEN is a direct target of miR-29a-3p, with PTEN enhancing miR-29a-3p's proliferative effect in AAA.

Conclusions:

  • miR-29a-3p directly targets PTEN, playing a significant role in regulating AAA development and progression.
  • The miR-29a-3p/PTEN axis represents a novel molecular mechanism in AAA pathogenesis.
  • This study provides insights for developing new therapeutic strategies targeting the miR-29a-3p/PTEN pathway for AAA treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K